Tinea pedis is a common and frequent disease in dermatology, and irregular diagnosis and treatment often lead to low cure rates and high recurrence rates of tinea pedis. In order to standardize the diagnosis and treatment of tinea pedis, experts from the Fungal Group of the Dermatology Branch of the Chinese Medical Association reached a consensus based on evidence-based medicine to meet the needs of the majority of dermatologists. The consensus reads as follows: 1. The causative agent of tinea pedis is dermatophytes. 2, The diagnosis of tinea pedis should be based on clinical manifestations combined with fungal culture and fungal microscopy. 3.The goal of tinea pedis treatment is to remove the causative organism, quickly relieve symptoms, and prevent recurrence. Local treatment, systemic treatment or combined treatment can be used for tinea pedis treatment. 4.Topical treatment is suitable for patients with incipient or limited lesions of tinea pedis. You can choose acrylamides or azoles as well as other types of topical antifungal drugs, and a full course of medication is required. 5.Systemic treatment is suitable for patients with poor results of local treatment, recurrent attacks, scaly keratinized type, large area of involvement, or those with certain systemic diseases (such as diabetes, AIDS, etc.) and those who do not want to receive local treatment. 6.The combination of topical and systemic treatment (one topical plus one oral antifungal) has advantages in shortening the course of treatment, reducing the cost, improving the compliance and efficacy, and reducing the recurrence rate; especially for those with recurrent attacks and poor compliance. 7.In the combined local and systemic treatment plan, oral drug is recommended to use terbinafine (Lymecloprid) for 1~2 weeks; topical drug can choose acrylamide, azole or other kinds of antifungal drugs. That is, “1+1” therapy